# FDA Inspection 805451 - LifeSource dba Central Blood Bank - October 30, 2012

Source: https://www.keypedia.com/records/fda_inspections/lifesource-dba-central-blood-bank/0c1e0f69-7ff9-4771-9490-850ec8bd56e2
Source feed: FDA_Inspections

> FDA Inspection 805451 for LifeSource dba Central Blood Bank on October 30, 2012. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 805451
- Company Name: LifeSource dba Central Blood Bank
- Inspection Date: 2012-10-30
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 910118 - 2015-01-14](https://www.keypedia.com/records/fda_inspections/lifesource-dba-central-blood-bank/e9b1044c-7a24-478d-aaf3-ee19b18862ce)
- [FDA Inspection 698002 - 2010-11-17](https://www.keypedia.com/records/fda_inspections/lifesource-dba-central-blood-bank/7f2e680f-88c8-4f90-a248-5d4d3150e050)
- [FDA Inspection 565164 - 2009-02-25](https://www.keypedia.com/records/fda_inspections/lifesource-dba-central-blood-bank/b17cfc91-a19d-4d59-9a6f-852a0d8c2a50)

Company: https://www.keypedia.com/companies/lifesource-dba-central-blood-bank/bd2c95bc-5022-4f97-be07-cbb9b6dc43d1

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d